Cargando…
Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies
BACKGROUND: Individual studies have suggested that some circulating fatty acids are associated with prostate cancer risk, but have not been large enough to provide precise estimates of associations, particularly by stage and grade of disease. METHODS: Principal investigators of prospective studies o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188122/ https://www.ncbi.nlm.nih.gov/pubmed/25210201 http://dx.doi.org/10.1093/jnci/dju240 |
_version_ | 1782338219482808320 |
---|---|
author | Crowe, Francesca L. Appleby, Paul N. Travis, Ruth C. Barnett, Matt Brasky, Theodore M. Bueno-de-Mesquita, H. Bas Chajes, Veronique Chavarro, Jorge E. Chirlaque, Maria-Dolores English, Dallas R. Gibson, Robert A. Giles, Graham G. Goodman, Gary E. Henning, Susanne M. Kaaks, Rudolf King, Irena B. Kolonel, Lawrence N. Kristal, Alan R. Neuhouser, Marian L. Park, Song-Yi Severi, Gianluca Siddiq, Afshan Stampfer, Meir J. Stattin, Pär Tangen, Catherine M. Tjønneland, Anne Trichopoulos, Dimitrios Tumino, Rosario Wilkens, Lynne R. Key, Timothy J. Allen, Naomi E. |
author_facet | Crowe, Francesca L. Appleby, Paul N. Travis, Ruth C. Barnett, Matt Brasky, Theodore M. Bueno-de-Mesquita, H. Bas Chajes, Veronique Chavarro, Jorge E. Chirlaque, Maria-Dolores English, Dallas R. Gibson, Robert A. Giles, Graham G. Goodman, Gary E. Henning, Susanne M. Kaaks, Rudolf King, Irena B. Kolonel, Lawrence N. Kristal, Alan R. Neuhouser, Marian L. Park, Song-Yi Severi, Gianluca Siddiq, Afshan Stampfer, Meir J. Stattin, Pär Tangen, Catherine M. Tjønneland, Anne Trichopoulos, Dimitrios Tumino, Rosario Wilkens, Lynne R. Key, Timothy J. Allen, Naomi E. |
author_sort | Crowe, Francesca L. |
collection | PubMed |
description | BACKGROUND: Individual studies have suggested that some circulating fatty acids are associated with prostate cancer risk, but have not been large enough to provide precise estimates of associations, particularly by stage and grade of disease. METHODS: Principal investigators of prospective studies on circulating fatty acids and prostate cancer were invited to collaborate. Investigators provided individual participant data on circulating fatty acids (weight percent) and other characteristics of prostate cancer cases and controls. Prostate cancer risk by study-specific fifths of 14 fatty acids was estimated using multivariable-adjusted conditional logistic regression. All statistical tests were two-sided. RESULTS: Five thousand and ninety-eight case patients and 6649 control patients from seven studies with an average follow-up of 5.1 (SD = 3.3) years were included. Stearic acid (18:0) was inversely associated with total prostate cancer (odds ratio [OR] Q5 vs Q1 = 0.88, 95% confidence interval [CI] = 0.78 to 1.00, P (trend) = .043). Prostate cancer risk was, respectively, 14% and 16% greater in the highest fifth of eicosapentaenoic acid (20:5n-3) (OR = 1.14, 95% CI = 1.01 to 1.29, P (trend) = .001) and docosapentaenoic acid (22:5n-3) (OR = 1.16, 95% CI = 1.02 to 1.33, P (trend) = .003), but in each case there was heterogeneity between studies (P = .022 and P < .001, respectively). There was heterogeneity in the association between docosapentaenoic acid and prostate cancer by grade of disease (P = .006); the association was statistically significant for low-grade disease but not high-grade disease. The remaining 11 fatty acids were not statistically associated with total prostate cancer risk. CONCLUSION: There was no strong evidence that circulating fatty acids are important predictors of prostate cancer risk. It is not clear whether the modest associations of stearic, eicosapentaenoic, and docosapentaenoic acid are causal. |
format | Online Article Text |
id | pubmed-4188122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-41881222014-10-16 Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies Crowe, Francesca L. Appleby, Paul N. Travis, Ruth C. Barnett, Matt Brasky, Theodore M. Bueno-de-Mesquita, H. Bas Chajes, Veronique Chavarro, Jorge E. Chirlaque, Maria-Dolores English, Dallas R. Gibson, Robert A. Giles, Graham G. Goodman, Gary E. Henning, Susanne M. Kaaks, Rudolf King, Irena B. Kolonel, Lawrence N. Kristal, Alan R. Neuhouser, Marian L. Park, Song-Yi Severi, Gianluca Siddiq, Afshan Stampfer, Meir J. Stattin, Pär Tangen, Catherine M. Tjønneland, Anne Trichopoulos, Dimitrios Tumino, Rosario Wilkens, Lynne R. Key, Timothy J. Allen, Naomi E. J Natl Cancer Inst Review BACKGROUND: Individual studies have suggested that some circulating fatty acids are associated with prostate cancer risk, but have not been large enough to provide precise estimates of associations, particularly by stage and grade of disease. METHODS: Principal investigators of prospective studies on circulating fatty acids and prostate cancer were invited to collaborate. Investigators provided individual participant data on circulating fatty acids (weight percent) and other characteristics of prostate cancer cases and controls. Prostate cancer risk by study-specific fifths of 14 fatty acids was estimated using multivariable-adjusted conditional logistic regression. All statistical tests were two-sided. RESULTS: Five thousand and ninety-eight case patients and 6649 control patients from seven studies with an average follow-up of 5.1 (SD = 3.3) years were included. Stearic acid (18:0) was inversely associated with total prostate cancer (odds ratio [OR] Q5 vs Q1 = 0.88, 95% confidence interval [CI] = 0.78 to 1.00, P (trend) = .043). Prostate cancer risk was, respectively, 14% and 16% greater in the highest fifth of eicosapentaenoic acid (20:5n-3) (OR = 1.14, 95% CI = 1.01 to 1.29, P (trend) = .001) and docosapentaenoic acid (22:5n-3) (OR = 1.16, 95% CI = 1.02 to 1.33, P (trend) = .003), but in each case there was heterogeneity between studies (P = .022 and P < .001, respectively). There was heterogeneity in the association between docosapentaenoic acid and prostate cancer by grade of disease (P = .006); the association was statistically significant for low-grade disease but not high-grade disease. The remaining 11 fatty acids were not statistically associated with total prostate cancer risk. CONCLUSION: There was no strong evidence that circulating fatty acids are important predictors of prostate cancer risk. It is not clear whether the modest associations of stearic, eicosapentaenoic, and docosapentaenoic acid are causal. Oxford University Press 2014-09-04 /pmc/articles/PMC4188122/ /pubmed/25210201 http://dx.doi.org/10.1093/jnci/dju240 Text en © The Author 2014. Published by Oxford University Press. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Crowe, Francesca L. Appleby, Paul N. Travis, Ruth C. Barnett, Matt Brasky, Theodore M. Bueno-de-Mesquita, H. Bas Chajes, Veronique Chavarro, Jorge E. Chirlaque, Maria-Dolores English, Dallas R. Gibson, Robert A. Giles, Graham G. Goodman, Gary E. Henning, Susanne M. Kaaks, Rudolf King, Irena B. Kolonel, Lawrence N. Kristal, Alan R. Neuhouser, Marian L. Park, Song-Yi Severi, Gianluca Siddiq, Afshan Stampfer, Meir J. Stattin, Pär Tangen, Catherine M. Tjønneland, Anne Trichopoulos, Dimitrios Tumino, Rosario Wilkens, Lynne R. Key, Timothy J. Allen, Naomi E. Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies |
title | Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies |
title_full | Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies |
title_fullStr | Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies |
title_full_unstemmed | Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies |
title_short | Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies |
title_sort | circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188122/ https://www.ncbi.nlm.nih.gov/pubmed/25210201 http://dx.doi.org/10.1093/jnci/dju240 |
work_keys_str_mv | AT crowefrancescal circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT applebypauln circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT travisruthc circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT barnettmatt circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT braskytheodorem circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT buenodemesquitahbas circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT chajesveronique circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT chavarrojorgee circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT chirlaquemariadolores circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT englishdallasr circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT gibsonroberta circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT gilesgrahamg circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT goodmangarye circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT henningsusannem circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT kaaksrudolf circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT kingirenab circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT kolonellawrencen circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT kristalalanr circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT neuhousermarianl circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT parksongyi circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT severigianluca circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT siddiqafshan circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT stampfermeirj circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT stattinpar circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT tangencatherinem circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT tjønnelandanne circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT trichopoulosdimitrios circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT tuminorosario circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT wilkenslynner circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT keytimothyj circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT allennaomie circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies AT circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies |